Know Where to Start with Pancreatic Cancer Clinical Trials
Pancreatic cancer clinical trials increasingly target KRAS — found in over 90% of tumors — so biomarker testing can open doors to new studies.
brca pancreatic cancer
Pancreatic cancer clinical trials increasingly target KRAS — found in over 90% of tumors — so biomarker testing can open doors to new studies.